Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$0.00
-28.0%
$0.03
$0.00
$0.22
$54K-0.3535,057 shs3,424 shs
QTXB
QuantRx Biomedical
$0.00
$0.00
$0.00
$39K-4.326,433 shsN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
$0.00
$0.00
$0.00
$17K-18.9117,300 shsN/A
SDCCQ
SmileDirectClub
$0.00
+∞
$0.00
$0.00
$0.01
$40K1.8764,863 shs99,866 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-28.00%0.00%-96.00%-96.40%-96.00%
QTXB
QuantRx Biomedical
0.00%0.00%0.00%-80.00%-97.50%
Regenicin, Inc. stock logo
RGIN
Regenicin
0.00%0.00%0.00%0.00%-98.00%
SDCCQ
SmileDirectClub
0.00%0.00%0.00%0.00%-96.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/AN/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
0.00
N/AN/AN/A
QTXB
QuantRx Biomedical
0.00
N/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
0.00
N/AN/AN/A
SDCCQ
SmileDirectClub
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
$7.16M0.01N/AN/A($0.03) per share-0.06
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
$470.74M0.00N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
-$81.66MN/A0.00N/A-272.74%-311.64%-11.57%N/A
QTXB
QuantRx Biomedical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
-$640KN/A0.00N/AN/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
-$86.40MN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/AN/AN/AN/AN/A
QTXB
QuantRx Biomedical
N/AN/AN/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
N/A
1.85
1.57
QTXB
QuantRx Biomedical
N/AN/AN/A
Regenicin, Inc. stock logo
RGIN
Regenicin
N/AN/AN/A
SDCCQ
SmileDirectClub
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
56.91%
QTXB
QuantRx Biomedical
N/A
Regenicin, Inc. stock logo
RGIN
Regenicin
0.01%
SDCCQ
SmileDirectClub
0.07%

Insider Ownership

CompanyInsider Ownership
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
5.21%
QTXB
QuantRx Biomedical
21.90%
Regenicin, Inc. stock logo
RGIN
Regenicin
N/A
SDCCQ
SmileDirectClub
64.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Acutus Medical, Inc. stock logo
AFIB
Acutus Medical
34029.78 million28.23 millionOptionable
QTXB
QuantRx Biomedical
N/A78.70 millionN/ANot Optionable
Regenicin, Inc. stock logo
RGIN
Regenicin
3165.77 millionN/ANot Optionable
SDCCQ
SmileDirectClub
2,700402.61 million142.12 millionOptionable

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Acutus Medical stock logo

Acutus Medical NASDAQ:AFIB

$0.0018 0.00 (-28.00%)
As of 11:45 AM Eastern

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

QuantRx Biomedical OTCMKTS:QTXB

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Regenicin stock logo

Regenicin OTCMKTS:RGIN

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

SmileDirectClub NASDAQ:SDCCQ

$0.0001 +0.00 (+∞)
As of 03:14 PM Eastern

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee. On January 26, 2024, the voluntary petition of SmileDirectClub, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 29, 2023..